All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. The tracked stories average 2 original sources each. C-MET appears in 1 tracked Cross-Sector story from March 11, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about C-MET
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. The tracked stories average 2 original sources each. C-MET appears in 1 tracked Cross-Sector story from March 11, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering C-MET. Shared-story counts are live from our verified record — not editorial picks.
Lords Mark Industries has entered a strategic partnership with the Center for Materials for Electronics Technology (C-MET) to develop a pioneering AI-based breast cancer detection device. This collaboration aims to leverage advanced materials and artificial intelligence to create a non-invasive, highly accurate screening tool for early-stage diagnosis.